Ophthalmic Consultants of Long Island: Clinical Trials

9 trials sponsored by Ophthalmic Consultants of Long Island, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 recruiting. 4 Phase 4, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Recruiting 1
Phase 22Completed 2
Phase 31Completed 1

Follow Ophthalmic Consultants of Long Island: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
Dexamethasone, Standard of care surgery - Patient Preference
Phase 4RecruitingOphthalmic Consultants of Long Island502019-11-042019-12-20
Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region
THERMIeyes® 20 RF System - Skin Laxity, Meibomian Gland Dysfunction
UnknownOphthalmic Consultants of Long Island302017-07-252017-09-12
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Intravitreal Aflibercept Injection (IAI) - Proliferative Diabetic Retinopathy
Phase 2 / Phase 3CompletedOphthalmic Consultants of Long Island202013-03-012016-06-06
Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond Laser
Cataract, Dry Eye
UnknownOphthalmic Consultants of Long Island402011-09-012016-04-25
Diurnal Variation in Tear Osmolarity
Dry Eye Disease
CompletedOphthalmic Consultants of Long Island602011-03-012016-04-25
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
Xalatan, Travatan Z - Dry Eye Disease
Phase 4CompletedOphthalmic Consultants of Long Island562008-10-012011-07-21
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances
Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo) - Decrease in Night Vision, Disturbance; Vision, Loss
Phase 2CompletedOpus Genetics, Inc242007-08-012024-02-15
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Lotemax, Restasis - Dry Eye Disease, Keratoconjunctivitis Sicca
Phase 4CompletedOphthalmic Consultants of Long Island52006-11-012011-07-21
Efficacy of Topical Cyclosporin for Ocular Rosacea
Cyclosporine 0.05%, Ocular lubricant - Rosacea
Phase 4CompletedOphthalmic Consultants of Long Island352006-06-012011-07-29

Conditions studied

Dry Eye Syndromes (4)  ·  Cataract (1)  ·  Cutis Laxa (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Hyperemia (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Meibomian Gland Dysfunction (1)  ·  Ocular Hypertension (1)  ·  Patient Preference (1)  ·  Rosacea (1)

Interventions

Cyclosporins (1)  ·  Dexamethasone (1)  ·  Ketorolac (1)  ·  Latanoprost (1)  ·  Loteprednol Etabonate (1)  ·  Moxifloxacin (1)  ·  Prostaglandins (1)  ·  Travoprost (1)  ·  aflibercept (1)

Countries

United States (9)

Top investigators

Barbara Burger, R.N. (1)  ·  Barbara Burger, RN (1)  ·  Eric D Donnenfeld, MD (1)  ·  Eric Donnenfeld, MD (1)  ·  Gerard D'Aversa, MD (1)  ·  Glenn L Stoller, MD (1)  ·  John R Wittpenn, MD (1)  ·  Marguerite McDonald, M.D. (1)  ·  Marguerite McDonald, MD, FACS (1)  ·  Maria Howard (1)

Results publications

PMID 25083776, PMID 36209072